A combined meeting of the Heberden Society, the British Association for Rheumatology and Rehabilitation, and the Section of Rheumatology and Rehabilitation of the Royal Society of Medicine was held at Owen's Park, Manchester, on 12-13 July 1979. The meeting consisted of (1) a symposium on the relevance of contemporary epidemiology to clinical rheumatology; (2) a scientific meeting consisting of 'free' papers selected by the societies; and (3) demonstrations which were intended to augment the scientific communications and to emphasise the shared aims and interests of health professionals and medically related industry.
THE SYMPOSIUM
The relevance of contemporary epidemiology to clinical practice in rheumatology. ARC Epidemiology Research Unit, University of Manchester (on the occasion ofthe 25th anniversary ofits establishment). Lilienfeld: The epidemiologist attempts to integrate data from diverse disciplines, evaluating the interaction of these factors relative to time, place and person.
Lalonde's new perspective: biological and genetic factors, environmental hazards, life style and behaviour, health care, and the organisation of services.
In considering the health of human populations from these points of view it is customary to follow one or more of Morris's approaches to epidemiology: 
efficiency-working ofhealth services
The main presentations at the symposium reviewed work appertaining to these considerations, with particular emphasis on relevance for clinical rheumatologists.
Medical characteristics in populations. J. H. Kellgren, Emeritus Professor of Rheumatology. Manchester. Some of the early studies of chronic rheumatic diseases in populations were described with special reference to the way in which the features of rheumatic diseases as observed in populations differ from those found in patients-especially those attending rheumatism clinics. The import of these findings on clinical practice and on our understanding of rheumatic diseases were diseussed.
Medical characteristics in patients-Identifying syndromes and the diagnostic process. Philip H N Wood. ARC Epidemiology Research Unit, University of Manchester.
Sophisticated epidemiological study of rheumatic disorders is handicapped by a series of generic problems: events are usually ill-defined; states express themselves in variable ways; methodology is cumbersome and blunt; disease concepts are unsatisfactory; causal models are obscure; and information to set the challenge in perspective has been deficient. The implications of these difficulties for research strategies were considered.
A key problem is nosological-rheumatic disorders lack a hallmark, a typical feature or test by which to identify a specific condition. Associated with this are difficulties with illness-disease discordance and heterogeneity. One response has been to assist with clinical studies of natural history-examining the basis on which diagnosis is made, and seeking syndromes within heterogeneous material (juvenile chronic arthritis is the prime example). Disease classification and nomenclature are also relevant, as is variability in geographical expression.
Illness in context-Behavioural characteristics in patients and populations. Michael R. Bury. ARC Epidemiology Research Unit, University of Manchester.
Rheumatology has long been concerned with psychological and social factors. The pioneering work of Sidney Cobb sought to account for the occurrence of RA by examining the family backgrounds of patients. He pointed to a possible link between types of familial experiences and the onset of disease. Despite the fact that this work was limited by its concern with causation, as other workers have indicated, interest in psychological and social aetiology remains. In recent years a wider view has emerged, focusing on the disabling consequences of rheumatic disease. Concern has shifted from identifying particular 'personality types' to the problems ofchronic illness and rehabilitation, and the resources that individuals are able to Peripheral arthritis is a well recognised feature of seronegative spondarthritis even when the spinal disease is predominant. The present study was undertaken to determine (1) if histocompatibility (14LA) typing was of the diagnostic value in those patients with seronegative oligoarthritis who lacked spinal and extra-articular features characteristic of this group of diseases, and (2) if HLA B27 positive patients had any distinguishing clinical features when compared with HLA B27 negative patients.
26 (20 male) consecutive patients with a seronegative peripheral oligoarthritis were studied clinically, had an AP pelvic radiograph and were HLA typed. Patients with definite radiological abnormailities of the sacroiliac joints were excluded. Their mean age was 25 * 3 years (range 9-64). None had more than 6 joints affected at once; 18 had two (12 patients) or one (6 patients) only involved. The lower limb weight bearing joints were most commonly affected 22 (84 6 %) patients had a synovitis of one or both knees and 7 (26 9 %) had low back or buttock pain and stiffness.
18 patients (14 male) were HLA B27 positive. Two had minor unilateral radiological abnormalities of the sacroiliac joints. B27 positive and negative patients did not significantly differ with respect of sex ratio, age of onset, number or site of joints affected. Five B27 positive patients gave a past history, or subsequently developed, extra-articular features characteristic of seronegative spondarthritis, but that did not coincide with the arthritis leading to their ascertainment. Two B27 positive males had first degree relatives with ankylosing spondylitis. Radiological evidence of ankylosing spondylitis was found in 20% of the males and 9% of the females in the population samples. In the family studies of probands with ankylosing spondylitis 50% of HLA B27 positive fathers and 5 % of HLA B27 positive mothers had ankylosing spondylitis, illustrating the familial aggregation of the disease. However, studies of identical twins showing discordance for the disease suggests an environmental factor is necessary for the disease to appear.
Analysis of the data suggests that there is an independently segregating gene, in addition to HLA B27, which predisposes to ankylosing spondylitis. Tienilic acid. Simultaneous regulation of gout and hypertension. J. A. Reardon, J. T. Scott. Kennedy Institute of Rheumatology, London. A major problem in the management of gout is control of frequently associated hypertension. Increase in serum uric acid with most diuretics either precipitates acute gout attacks or requires larger, doses of uricosurics or allopurinol.
Tienilic acid, a diuretic with uricosuric properties, has been reported to lower serum uric acid levels in hypertension, but its potential has not been previously assessed in gouty patients.
Maintained on a low-purine diet through the 21 days of their admission, 4 patients with gout and hypertension received varying doses of tienilic acid. Detailed measurements were made of urinary uric acid excretion (collected 4-hourly throughout), serum acid uric (8-hourly) plasma and urine electrolytes, fluid balance and resting blood pressure (4-hourly) .
Serum uric acid fell by an average 4 5 mg % (0-27 mmol/l) to values well within the normal range. Urinary uric acid altered little with single daily dosage, but increased significantly with a twice daily regimen. Reduction in diastolic blood pressure was seen in all cases producing an average drop of 22 mmHg.
Conclusions: (1) Tienilic acid is a potentially major advance in management of the hypertensive gouty patient. (2) Detailed controlled inpatient studies reveal that twice daily dosage is required for satisfactory reduction in serum uric acid. (3) The presence of MMA has been sought in pelvic radiographs in 273 patients with a variety of disorders (see Table) . In 109 consecutive admissions to a rheumatology hospital, where pelvic radiographs were available, MMA was seen in 7; all 7 were rheumatoid patients who had been receiving long-term steroid therapy. Ninety-one patients attending the Mineral Metabolism Unit at Leeds General Infirmary were reviewed; MMA was present in 14 patients and was strongly associated with severe osteoporosis whether or not steroid induced. The relationship to steroid therapy was less strong in a group of patients with severe chronic renal failure attending a renal unit for dialysis or following renal transplantation. In itself MMA represents a benign complication of steroid therapy though it may indicate the presence of significant bone disease. (1) and 9% of group (2) had the drug withdrawn because of an AR. 65% of all group (1) ARs occurred during the first 3 months of treatment when skin rashes, taste impairment, and gastrointestinal disturbances were most common. Renal and haemopoietic abnormalities tended to present later. Multiple ARs were common, less so in those developing renal or haemopoietic complications. Two patients died, 1 with multiple pulmonary abscesses, hemiparesis, and thrombocytopenia, and the other of septicaemia with marrow failure.
It is concluded that a substantial number of serious ARs occur in association with the administration of D-P. Early ARs are more frequent, but serious reactions may occur after many months of treatment. (Note: These are provisional figures, as data still being received).
Comparison of gold, penicilamine, and levamisole in treatment of rheumatoid arthritis. H. A. Capell, J. A. N. Rennie, P. J. Rooney, D. Spencer, W. C. Dick. Recent multicentre studies12 have compared different dose regimens of levamisole in the treatment of patients with rheumatoid arthritis. In view of the potential benefit and toxicity of this drug we consider that data comparing levamisole at different doses with established second-line drugs are urgently required.
Seventy-five patients were randomly allocated to treatment with either gold, penicillamine, or levamisole. The dose of levamisole was 150 mg/day on 3 consecutive days each week and gold and penicillamine were given in conventional dosage. Clinical and laboratory assessments were done at 3 and 6 months.
Of the 25 patients who commenced each drug, 16 remained on gold at the end of 6 months compared with 18 on penicillamine and 9 on levamisole. There was no significant difference in the overall clinical and laboratory response of these patients. Four patients in the levamisole group, all of whom had responded well, developed leucopenia compared with one patient on gold. There was a more rapid drop-out rate on levamisole 3 days/week than in a previous study from this centre using levamisole 7 days/week3. This new compound inhibits the chronic phase of adjuvant arthritis in rats but is essentially devoid of both acute anti-inflammatory and analgesic activity in animal studies. These properties prompted studies in rheumatoid arthritis.
Forty patients with classical or definite rheumatoid arthritis who were taking stable doses of NSAID but required more specific therapy were treated with either penicillamine or ICI 55897 at 100 mg or 300 mg daily for a period of 6 months. Clinical assessments suggested that ICI 55897 was effective, but less so than penicillamine. Laboratory data showed a similar fall in ESR and acute phase proteins in all groups. Side effects in patients taking 100 mg ICI 55897 daily were nil, suggesting that this drug could provide a safer alternative to gold and penicillamine.
Treatnent of fibrosing alveolitis with penicilamine and methotrexate. D. G. I. Scott, R. C. Bucknall, P. A. Bacon. Royal National Hospital for Rheumatic Diseases.
Fibrosing alveolitis (FA) is a well recognised complication of rheumatoid arthritis (RA) and other connective tissue diseases and is thought to relate to circulating immune complexes. Conventional treatment with corticosteroids has been disappointing so alternative drugs, including immunosuppressants, are now being used. The response to penicillamine, which is known to effect systemic RA and immune complexes has not been well documented.
Penicillamine was given to 9 patients with FA followed over a period ranging from 5 months to 4 years. Clinical assessment, chest radiographs and pulmonary function tests were performed before and at regular intervals during treatment. Methotrexate was given to 3 patients with FA, followed over a period ranging from 10 months to 2 years and similarly studied.
Penicillamine had little overall effect (Table) .
By contrast methotrexate resulted in symptomatic improvement in all 3 patients, radiographic improvement in 2, and significant improvement of lung function in 1 (Table 1) . Some improvement in carbon monoxide transfer occurred in all 3 patients compared with improvement of 3 patients treated with penicillamine and deterioration in 6. Two of the patients treated with methotrexate had deteriorated during previous treatment with penicillamine and 1 group.bmj.com on November 7, 2017 -Published by http://ard.bmj.com/ Downloaded from With a modified Boyden chamber (3 um Micropore filters) cell migration was measured by the leading front method after 20 minutes' incubation. Both random and directed locomotion were normal in patients with RA alone but significantly impaired in those with RA plus neutropenia. Directed migration was tested in the presence of serum, and all RA sera supported migration as efficiently as did normal serum, suggesting that this impaired migration reflected a cellular defect. Analysis of the data by computer-linked image analysis (Quantimet) showed that this slowing of the leading front measurement was due to an overall showing of all cells rather than depletion of a more mobile subset.
Patients with RA alone had a significant neutrophilia compared with normal controls. Studies of PMN adhesiveness using nylon fibre columns' showed the proportions of adhesive to nonadhesive cells to be the same between all 3 groups. Analysis of PMN electrophoretic mobility between these groups showed that all patients with RA had a decrease in the proportion of cells with a high surface charge when compared with normals. Changes in cell migration correlated neither with cell adhesiveness nor with electrophoretic mobility. It is suggested that measurement of antibody levels to native collagen, especially type 1, may be a useful marker of erosive disease. Sequential studies on patients are in progress and it is hoped to report these at the meeting. (PMR) in 263 patients who were thought unequivocally to be suffering from this condition. We also mentioned that 70 patients who might possibly have had PMR were also being studied.
These patients with possible PMR have now been followed up after an interval of approximately 3 years. Their clinical status has been assessed, the most likely diagnosis of their original problem has been reviewed in retrospect, and the discriminatory performance of the proposed criteria originally fulfilled has been analysed.
Our proposed criteria were not applied in the possible cases in our original analysis. It is encouraging that, of those fulfilling 3 criteria, the response to a therapeutic test with prednisolone provided very good discrimination. In the largest series of cases from one centre, of 15 with 3 criteria 8 had a positive steroid test and all had PMR; 4 had a negative test and on review had RA or OA; and in 3 in whom the test was not done the diagnosis remained uncertain.
We have also explored the value of less stringent models, requiring the presence of only 2 criteria if there was also a response to prednisolone. Once again the results in those with possible PMR were encouraging, although reanalysis of our original data from this point of view does not support the idea that the minimal number of criteria might be reduced other than in very specific circumstances.
Longitudinal studies of circulating immune complexes and acute phase reactants in polymyalgia rheumatica and giant cell arteritis. J. Park, J. G. Jones, B. L. Hazleman. Addenbrooke's Hospital, Cambridge. The relationship between acute phase reactants, immune complexes, and disease activity was studied in 108 patients with polymyalgia rheumatica and/or giant cell arteritis.
The erythrocyte sedimentation rate (ESR) is the acute phase reactant commonly measured. However, it can be unreliable as an indicator of disease activity. Other acute phase reactants measured were C-reactive protein (CRP), xc antitrypsin, orosomucoid, and haptoglobin. Jmmune complexes were measured by the polyethyleneglycol precipitation complement consumption assay.1 44% of an active untreated group (21 patients) had increased levels of immune complexes whereas 23 of an inactive group (49 patients) were raised. They were increased in patients with arteritis.
Detailed longitudinal studies revealed a good correlation between CRP, ESR, and disease activity. It is concluded that the additional measurements of immune complexes and acute phase reactants are no better at reflecting fluctuations in disease activity than the ESR. The prognosis and management of polymyaWa rheumatica (PMR). J. G. Jones, B. L. Hazleman. Addenbrooke's Hospital, Cambridge. PMR is considered a benign disease by some' while others2 think it is a more serious illness which requires similar treatment to giant cell arteritis. The progress of 85 patients with PMR who presented to a district general hospital has been studied in an attempt to study this relationship.
Thirty-eight patients had PMR alone, 14 developed PMR and GCA within one month. Five patients presented with GCA and then developed PMR and 28 patients developed symptoms of GCA after presenting with PMR (PMR to GCA). The mean interval from onset of PMR to onset of symptoms of GCA was 1 year (1 month-9 years).
Twenty-two patients (25%) developed some cerebral or visual complication (see Table) . 15 of these patients were in the PMR-GCA group. Seven patients developed complications while on corticosteroids. Several patients had more than one complication.
All but 6 patients were treated with corticosteroids. Nine patients were able to stop treatment but the remainder still require therapy.
In this group of patients PMR appears to result in potentially serious complications in 25 % of patients. Low doses of steroids did not always prevent these side effects occurring. with congenital heart disease and hypertension were examined. A high incidence of immunological abnormalities was found (see Table) . The autoantibodies found in the various conditions differed: in IPH they were mainly antinuclear and antithymic; smooth muscle antibodies were only found in patients with congenital heart disease; the patients with rheumatic heart disease had a mixture of autoantibodies. Small quantities of circulating immune complexes were found in all groups. All these 17 patients had two auto-antibodies. IgGRF and IgM RF by radioimmunoassay. IPH=idiopathic pulmonary hypertension.
SPH=secondary pulmonary hypertension. CHD=congenital heart disease.
Rheumatoid factors of both IgG and IgM type were raised in patients with both IPH and hypertension secondary to rheumatic heart disease but not when congenital heart disease was the cause of pulmonary hypertension. From these studies no clinical evidence of a generalised systemic disease, such as is found in the unusual types of connective tissue disease has been found in IPH. But there is strong evidence of an immunological basis for this disease, and this may offer hope of a method of treatment for this usually fatal disease.
OA-Should the patient lose weight? Elvet E. Smith, Philip N. H. Wood, ARC Epidemiology Research Unit, University of Manchester. A patient presenting with pain in the knees and evidence of osteoarthrosis (OA) is usually advised to reduce weight. The scientific basis for this advice is particularly the work of Kellgren and Lawrence,1 who demonstrated a relationship between assessments of obesity and the overall severity of radiographic changes in OA. However, the association is not observed in all populations, and some clinicians have expressed doubts about the link.
In order to explore this association further we have reviewed data from a larger sample-the original report was based on those aged 55-64, and cohort effects might have been observed. The radiographs were reread so as to distinguish between osteophytosis and evidence of joint damage in the different compartments of the knee. Obesity was assessed by the more sensitive Quetelet's (Q) index (weight . height2).
Because different observations have been made one would expect the results to differ also. Just as the pattern of distribution with age is different between osteophytosis and joint narrowing, so their relationship with degrees above or below the Q index mean for age varies as well. When the differences between medial and lateral compartments are taken into account the associations become far more complex. Although dispatching a patient with one problem, painful knees, after inflicting a second problem, dieting, may promote relief of symptoms, the aetiological significance of obesity in regard to OA knees is far from straightforward. It is difmcult to obtain an objective measure of the size of an individual muscle. In a needle biopsy study of quadriceps wasting following lower leg fracture and subsequent knee immobilisation 1 measurements ofmuscle fibre size suggested that quadriceps wasting might sometimes be much greater than would be expected from anthropometric estimates of fatfree thigh volume. Grey-scale ultrasonography can produce an image of the quadriceps muscle from which it is possible to measure its cross-sectional area (CSA). The between-days coefficient of variation for quadriceps CSA (at mid-thigh) in 14 legs of 7 subjects each scanned on 4 days was reduced to 4 * 0 % by averaging 4 scans on each day.
Bilateral scans at the mid-thigh level were used to measure the severity of quadriceps wasting in otherwise healthy adult patients with at least 2 cm discrepancy in thigh circumference following unilateral knee immobilisation or injury. Quadriceps wasting as demonstrated by the scans was consistently more severe than the disparity in thigh crosssectional area at the same level or the disparity in anthropometric estimates of fat-free thigh volume. The extent to which measurements of thigh circumference may underestimate the severity of quadriceps wasting must be recognised if clinical measurements are to be correctly interpreted. A lengthy enumeration of disabilities present can be daunting for all concerned. For research purposes Guttmann scaling has been used for simplification, with the assumption that activities can be ordered so that inability to perform one would imply inability with those further up the scale. However, this empirical approach offers little to the clinical teamthey cannot avoid all the diverse individual problems and the implication that each need should be met.
The interrelationship between various disabilities can be approached in other ways. We have studied the range of disabilities in individuals with RA, OA, and back troubles, using these as models for polyarticular, monarticular, and spinal involvemeni in the light of clusters of activities identified previously.1 Comparison between the groups highlighted the dominant influences of age and sex and of features associated with these, such as living alone. After allowing for these we have explored the interdependence of different disabilities.
The patterns of disabilities were much as would be expected on the basis of clinical experience and the features of the underlying conditions. However, the attempt to display regularities in these relationships has proved instructive. The results suggest ways in which the process of assessment might be simplified, with potential implications for clinical practice as well as research. A pilot study suggested that discontinuation of drug treatment was common among rheumatic patients.
119 (3 Y.) An earlier 20 year follow-up of 189 Harrogate patients with RA1 demonstrated that in both sexes and at all ages mortality was higher than in the general population of England, and that this was correlated with the initial grade of functional impairment However, deaths from the individual causes were too few to establish satisfactorily any excess or deficit of particular diseases.
Because of the theoretical interest of positively and negatively associated conditions (including suggested deficits of myocardial infarction and excesses of infection and renal disease), an attempt has been made to augment these data by 20 year follow-up of 252 Hammersmith patients (Bywaters) and 307 Edinburgh patients (Duthie).
The results permit calculation of the degree of under-reporting of RA on death certificates, which allows overall prevalence estimates to be generated from routine mortality statistics. The generally reduced chances of survival in RA were confirmed, as were various features associated with an unfavourable outcome.
Even with this large series of cases there is difficulty in assessing the significance of the association of certain causes of death (e.g., suicide remained in group I (9 on steroids, mean dose 9 5 mg/day) and 22 in group H. Thirty-seven patients in all received steroid therapy. In the majority of parameters the patients remaining in group I were better than in group II and in several of these the differences achieved statistical significance. Seven of the group I patients died (2 steroid related, 0 disease related) and 8 of group II (0 disease related 1 treatment related). Four patients, 2 from each group, suffered vertebral body collapse, but all had severe disease, had failed the initial treatment programmes, and were in the final common regime. Other side effects of treatment were comparable in the 2 groups. The patients who failed the 2 regimens ended up receiving similar forms of treatment. At the end of 10 years the clinical and laboratory parameters in these patients were very similar.
We conclude that maintenance of physical activity combined with the responsible use of steroids when necessary may be regarded as a useful form of treatment in early rheumatoid arthritis.
Unusual collagenase and gelatinase enzymes in immature pig intervertebral discs. Ian Tomlinson, M. I. V. Jayson, Jacqueline B. Weiss. Rheumatic Diseases Centre, University of Manchester. A collagenase capable of attacking the helical portion of the collagen molecule has been demonstrated from day 1 in both annulus and nucleus of pig intervertebral disc. Unlike normal mammalian collagenases this enzyme is not inhibited by EDTA. On the contrary concentrations of 5 mM EDTA and over actually enhance the activity. The enzyme is present in the free form but it can be activated by mersalyl, suggesting it is also present as an enzyme inhibitor complex. When EDTA and mersalyl are added together to the incubation mixture, the activation by mersalyl is further enhanced.
Enzymes capable of acting on a gelatin substrate are also present in the annulus of discs from day one but cannot be detected in the nucleus of corresponding discs. These enzymes are always present in the active form and treatment with mersalyl tends to mildly inhibit. Treatment with EDTA activates one of those enzymes and inhibits another.
Identification of collagenase and other neutral proteinases in human intervertebral discs. S. K. A. Sedowofia, I. Tomlinson, M. I. V. Jayson, Jacqueline B. Weiss. Rheumatic Diseases Centre, University of Manchester. Collagenolytic enzymes have been directly extracted from human intervertebral disc by a method which partially denatures the collagen matrix.1 These enzymes have been detected and identified in crude mixtures by means of an assay system which employs specific substrates carrying a tritium label. 2 At least 2 neutral proteinases in addition to collagenase have been detected. The collagenase is inhibited by EDTA but not to any significant extent by cysteine. It is present in a free form as well as in an enzyme-inhibitor complex which can be activated by mersalyl. In contrast other thiol blocking agents such as PCMB inhibit the enzyme slightly. A neutral proteinase with high activity against a gelatin substrate is present in free as well as in a zymogen form but is not apparently present as an enzyme inhibitor complex.
Free endogenous inhibitors of neutral porteinase activity have also been demonstrated in disc tissue.
After embryological development the nucleus pulposus (NP) is enclosed within the annulus fibrosus (AF) and from an immunological viewpoint has been considered to be a sequestered antigen. Rupture of the AF and posterior longitudinal ligament occurs in the prolapsed intervertebral disc (IV) syndrome, exposing the NP to immunocompetent cells. Several authors have considered autoimmunity as a possible aetiological factor1 in lumbar disc disease, and others believe that autoimmunity could contribute to the chronicity of symptoms.2 If valid, these concepts could have important diagnostic therapeutic and prognostic implications.
The purpose of our study was to investigate the possible existence of an autoimmune basis. Twenty patients with prolapsed lumbar IV discs with positive myelograms, who were subsequently treated surgically and an equal number of age and sex-matched controls were studied. Soluble antigens were prepared from JV discs obtained from a fresh young human cadaver. Lymphocyte transformation, immunoglobulin quantitation, C-reactive protein and ESR were performed. Our results showed no significant differences in any of the above indices between patients and controls. We were unable to confirm by our methods the existence of an autoimmune basis for intervertebral disc disease. Annular tears in the dorsolumbar spine (D10-L5). R. C. Hilton, J. Ball, R. T. Benn. Department of Rheumatology, University of Manchester and Hope Hospital, Salford. The distribution and severity of anterior and posterior annular tears in the dorsolumbar spine have been studied in 52 female and 65 male postmortem spines (aged 13-96 yr) using sagittal slabs of the discs and vertebral bodies. The findings were correlated with angular sagittal mobility.
Results: (1) The number of cases with tears in multiple discs increases with age but exceptions to this trend occur in both young and elderly spines. (2) Correlation coefficients indicate that anterior and posterior tears at L4 and L5 do not predict tears at other levels. At L3 and above significantly positive correlations occur between multiple disc levels particularly posteriorly. (3) The severity pattern for anterior and posterior annular tears differs with respect to age in cases >50 yr. the mean anterior tear score rises sharply from L5 to peak at L2 and Li in both sexes; in contrast the mean posterior tear score falls from L4 to Li in this age group. (4) The increase in severity of anterior tears corresponds with increased mobility in L4-L1 discs from 50-70 yr. In contrast mobility of the L5 disc falls progressively with age.
Conclusions. The data are compatible with 2 factors causing tears posteriorly one affecting L4 and L5 in young adults, and a second operating at a later age and promoting widespread disc involvement. The increased prevalence and severity of anterior tears (and the associated increase in mobility) in the upper lumbar region in the middle aged and elderly may be a pathogenic factor in back pain for this age group. Computed tomography (CT) is an x-ray transmission technique providing transaxial sections approximately 1 cm in thickness. The method permits the demonstration of spinal topographical anatomy against a detailed background of paravertebral structures and body cavity organs. In particular it enables precise identification of apophyseal joints to be made together with their relationship to the spinal canal and the intervertebral foraminae. Over 3000 patients have been investigated on the EMI CT5005 General Purpose Scanner in the Department of Diagnostic Radiology, University of Manchester Medical School, since 1976. The spine has been imaged in all patients but particular attention has been directed to some 300 patients presenting with spinal disorders. Computer assisted myelography with a water-soluble contrast medium (metrizamide) has been employed in the demonstration of neural tissue and the pathological processes affecting it. The movement of metrizamide in neural tissue has been explored. Current research is directed towards the value of higher resolution and reduced section thickness in the demonstration of neutral tissue without contrast medium. The application of the technique in the study of a variety of structural disorders will be discussed and illustrated CT is particularly valuable in identifying and localising spinal canal stenosis and apophyseal joint disease. The digital nature of the image allows access to the quantitative study of trabecular bone. The anatomical configuration of the spine together with restricted section thickness at present place constraints on the role of CT as a screening procedure in the investigation of spinal disorders.
